Ads
-
Related paper
- EFFECT OF DRUG THERAPY SUBCLINICAL HYPERTHYROIDIS M ON MARKERS OF CARDIOVASCULAR RISK IN PATIENTS WITH TYPE 2 DIABETES
- GLYCOSYLATED HEMOGLOBIN AS A RISK ASSESSMENT OF THE CARDIOVASCULAR LESIONS IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
- Atherogenic Dyslipidemia: An Important Risk Factor for Cardiovascular Disease in Metabolic Syndrome and Type 2 Diabetes Mellitus Patients
- A comparative study on the fasting and post prandial lipid levels as a cardiovascular risk factor in patients with type 2 diabetes mellitus
- Hepatic fibrosis as an additional risk factor for the development of cardiovascular disorders in patients with type 2 diabetes mellitus with non-alcoholic fatty liver disease
- Study of subclinical hypothyroidism among patients with type 2 diabetes mellitus
- SUBCLINICAL HYPOTHYROIDISM AND ITS ASSOCIATED COMPLICATIONS IN TYPE 2 DIABETES MELLITUS PATIENTS
- Novel cardiovascular risk markers in hypothyroidism patients
- Prevalence of Risk Factors for Cardiovascular Disease in Adolescents with Type 1 Diabetes
- NEW ATHEROGENIC INDICES AND LIPID PROFILE IN ASSESSMENT OF CARDIOVASCULAR RISK IN TYPE-1 DIABETES